ProShare Advisors LLC Purchases 19,018 Shares of CVS Health Corporation $CVS

ProShare Advisors LLC increased its holdings in shares of CVS Health Corporation (NYSE:CVS) by 7.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 264,715 shares of the pharmacy operator’s stock after acquiring an additional 19,018 shares during the quarter. ProShare Advisors LLC’s holdings in CVS Health were worth $21,008,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd raised its stake in CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 281 shares in the last quarter. Ares Financial Consulting LLC acquired a new stake in shares of CVS Health during the 4th quarter worth approximately $29,000. Dogwood Wealth Management LLC increased its stake in CVS Health by 93.7% in the fourth quarter. Dogwood Wealth Management LLC now owns 370 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 179 shares during the last quarter. GoalVest Advisory LLC acquired a new position in CVS Health during the fourth quarter valued at approximately $32,000. Finally, Financial Consulate Inc. lifted its stake in CVS Health by 99.6% during the fourth quarter. Financial Consulate Inc. now owns 499 shares of the pharmacy operator’s stock worth $40,000 after purchasing an additional 249 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Trading Down 0.8%

CVS opened at $93.45 on Thursday. The stock has a market cap of $119.24 billion, a PE ratio of 41.17, a price-to-earnings-growth ratio of 0.92 and a beta of 0.60. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78. CVS Health Corporation has a twelve month low of $58.50 and a twelve month high of $98.43. The company has a fifty day moving average of $79.69 and a 200-day moving average of $78.87.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, beating analysts’ consensus estimates of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The business had revenue of $100.43 billion for the quarter, compared to analysts’ expectations of $94.99 billion. During the same quarter in the prior year, the firm posted $2.25 earnings per share. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, sell-side analysts predict that CVS Health Corporation will post 7.44 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date was Thursday, April 23rd. CVS Health’s payout ratio is presently 117.18%.

Insider Transactions at CVS Health

In other CVS Health news, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the transaction, the executive vice president directly owned 10,133 shares of the company’s stock, valued at approximately $907,714.14. The trade was a 87.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.85% of the company’s stock.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS highlighted new community and workforce initiatives, including support for military families, a mobile food and chronic-care program in Louisiana, and an online pre-pharmacy degree program with WGU, all of which reinforce its health-care and talent pipeline strategy. CVS Health Reinforces Longstanding Support for the Military Community
• Positive Sentiment: Investors are also focused on bullish commentary about CVS as a “trending stock” and a potential rally that could continue, which may be reinforcing momentum in the shares. CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
• Positive Sentiment: CVS-related coverage continued to emphasize its health-care reach and dividend appeal, helping support investor interest in the name. CVS Health Stock Is Soaring. Could the Rally Just Be Getting Started?
• Neutral Sentiment: A CVS study found many Medicare members lack digital health literacy, which underscores a consumer-service challenge but does not appear to be a direct financial catalyst. Medicare members lack digital health literacy: CVS study
• Negative Sentiment: More importantly, University of Michigan hospitals alleged CVS diverted $66 million in a “secret pricing scheme,” which could raise legal, reputational, and regulatory overhang for CVS Health. CVS diverted $66M in ‘secret pricing scheme,’ University of Michigan hospitals allege

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CVS. HSBC lifted their price target on CVS Health from $83.00 to $85.00 and gave the company a “hold” rating in a research note on Tuesday, May 5th. Wolfe Research dropped their target price on shares of CVS Health from $100.00 to $97.00 and set an “outperform” rating for the company in a report on Monday, March 2nd. The Goldman Sachs Group raised their price target on shares of CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Wells Fargo & Company lifted their price target on shares of CVS Health from $102.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, May 8th. Finally, Bank of America lowered their price objective on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research report on Tuesday, January 27th. Twenty-two equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $98.68.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.